Circulating Levels of Human salusin-β,a Potent Hemodynamic and Atherogenesis Regulator

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Fujimoto, Kazumi ^a,b   Hayashi, Akinori ^b   Kamata, Yuji ^b   Ogawa, Akifumi ^b   Watanabe, Takuya ^c   Ichikawa, Raishi ^b   Iso, Yoshitaka ^d   Koba, Shinji ^d   Kobayashi, Youichi ^d   Koyama, Takatoshi ^a   Shichiri, Masayoshi ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^d SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE; SALUSIN BETA; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VASOPRESSIN;

ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; BODY POSTURE; CARBOXY TERMINAL SEQUENCE; CEREBROVASCULAR DISEASE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES INSIPIDUS; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPOPITUITARISM; IMMUNOREACTIVITY; MALE; NORMAL HUMAN; PROTEIN BLOOD LEVEL; REVERSED PHASE LIQUID CHROMATOGRAPHY; SMOKING; VASOPRESSIN RELEASE; WATER LOADING;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES; ATHEROSCLEROSIS; CEREBROVASCULAR DISORDERS; CHICKENS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCADIAN RHYTHM; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODYNAMICS; HUMANS; HYPOPITUITARISM; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; RABBITS; REFERENCE VALUES;

EID: 84884842682     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076714     Document Type: Article

References (21)

1. Takenoya F, Hori T, Kageyama H, Funahashi H, Takeuchi M, et al. (2005) Coexistence of salusin and vasopressin in the rat hypothalamo-hypophyseal system. Neurosci Lett 385: 110-113. doi:10.1016/j.neulet.2005.05.061. PubMed: 15961227.
2. Suzuki N, Shichiri M, Akashi T, Sato K, Sakurada M, et al. (2007) Systemic distribution of salusin expression in the rat. Hypertens Res 30: 1255-1262. doi:10.1291/hypres.30.1255. PubMed: 18344632.
3. Saito T, Dayanithi G, Saito J, Onaka T, Urabe T, et al. (2008) Chronic osmotic stimuli increase salusin-β-like immunoreactivity in the rat hypothalamo-neurohypophyseal system: possible involvement of salusin-β on [Ca2+]i increase and neurohypophyseal hormone release from the axon terminals. J Neuroendocrinol 20: 207-219. PubMed: 18047553.
4. Suzuki N, Shichiri M, Tateno T, Sato K, Hirata Y, (2011) Distinct systemic distribution of salusin-α and salusin-β in the rat. Peptides 32: 805-810. doi:10.1016/j.peptides.2010.12.012. PubMed: 21193001.
5. Shichiri M, Ishimaru S, Ota T, Nishikawa T, Isogai T, et al. (2003) Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities. Nat Med 9: 1166-1172. doi:10.1038/nm913. PubMed: 12910263.
6. Izumiyama H, Tanaka H, Egi K, Sunamori M, Hirata Y, et al. (2005) Synthetic salusins as cardiac depressors in rat. Hypertension 45: 419-425. doi:10.1161/01.HYP.0000156496.15668.62. PubMed: 15699450.
7. Watanabe T, Nishio K, Kanome T, Matsuyama TA, Koba S, et al. (2008) Impact of salusin-α and-β on human macrophage foam cell formation and coronary atherosclerosis. Circulation 117: 638-648. doi:10.1161/CIRCULATIONAHA.107.712539. PubMed: 18212280.
8. Nagashima M, Watanabe T, Shiraishi Y, Morita R, Terasaki M, et al. (2010) Chronic infusion of salusin-α and-β exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice. Atherosclerosis 212: 70-77. doi:10.1016/j.atherosclerosis.2010.04.027. PubMed: 20684826.
9. Gardiner SM, Keyte J, Bennett T, (2007) Reply to 'Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities'. Nat Med 13: 661; author reply:-662. doi:10.1038/nm0607-661b. PubMed: 17554326.
10. Shichiri M, (2007) Reply to 'Salusins; newly identified bioactive peptides with hemodynamic and mitogenic activities'. Nat Med 13: 661-662. doi:10.1038/nm0607-661b. PubMed: 17554326.
11. Sato K, Sato T, Susumu T, Koyama T, Shichiri M, (2009) Presence of immunoreactive salusin-β in human plasma and urine. Regul Pept 158: 63-67. doi:10.1016/j.regpep.2009.07.017. PubMed: 19660505.
12. Shichiri M, (2008) Method for producing comprehensive anti-surface antibodyα wherein the antigen used is a microorganism fixed by a protein crosslinking and fixation reagent. WO2010071237 A1 PCT/JP2009/071716.
13. Sato K, Koyama T, Shichiri M, (2008) Biosynthesis and secretion of salusin-α from human cells. Peptides 29: 2203-2207. doi:10.1016/j.peptides.2008.08.015. PubMed: 18804130.
14. Sato K, Fujimoto K, Koyama T, Shichiri M, (2010) Release of salusin-β from human monocytes/macrophages. Regul Pept 162: 68-72. doi:10.1016/j.regpep.2010.02.010. PubMed: 20176058.
15. Kimoto S, Sato K, Watanabe T, Suguro T, Koyama T, et al. (2010) Serum levels and urinary excretion of salusin-α in renal insufficiency. Regul Pept 162: 129-132. doi:10.1016/j.regpep.2010.03.009. PubMed: 20346378.
16. Sato K, Koyama T, Tateno T, Hirata Y, Shichiri M, (2006) Presence of immunoreactive salusin-α in human serum and urine. Peptides 27: 2561-2566. doi:10.1016/j.peptides.2006.06.005. PubMed: 16889872.
17. Watanabe T, Suguro T, Sato K, Koyama T, Nagashima M, et al. (2008) Serum salusin-α levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients. Hypertens Res 31: 463-468. doi:10.1291/hypres.31.463. PubMed: 18497465.
18. Watanabe T, Sato K, Itoh F, Iso Y, Nagashima M, et al. (2011) The roles of salusins in atherosclerosis and related cardiovascular diseases. J Am Soc Hypertens 5: 359-365. doi:10.1016/j.jash.2011.06.003. PubMed: 21925457.
19. Watanabe T, Sato K, Itoh F, Wakabayashi K, Shichiri M, et al. (2012) Endogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart disease. Sensors (Basel) 12: 4974-4985. doi:10.3390/s120404974. PubMed: 22666071.
20. Koya T, Miyazaki T, Watanabe T, Shichiri M, Atsumi T, et al. (2012) Salusin-β accelerates inflammatory responses in vascular endothelial cells via NF-κB signaling in LDL receptor-deficient mice in vivo and HUVECs in vitro. Am J Physiol Heart Circ Physiol 303: H96-105. doi:10.1152/ajpheart.00009.2012. PubMed: 22561298.
21. Ti Y, Wang F, Wang ZH, Wang XL, Zhang W, et al. (2011) Associations of serum salusin-α levels with atherosclerosis and left ventricular diastolic dysfunction in essential hypertension. J Hum Hypertens.